Search

Your search keyword '"Talarico R"' showing total 504 results

Search Constraints

Start Over You searched for: Author "Talarico R" Remove constraint Author: "Talarico R"
504 results on '"Talarico R"'

Search Results

1. End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer

4. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study

9. Systemic vasculitis: one year in review 2024

11. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

12. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: insights from the START Study

13. Systemic vasculitis: one year in review 2022

14. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET

15. AB0773 IMPROVING ADHERENCE TO TREATMENT IN BEHÇET’S DISEASE - THE MULTI-STAKEHOLDER IMPACT_BD INTERNATIONAL STUDY

19. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.

20. Systemic vasculitis: one year in review 2023

23. COVID-19: The new challenge for rheumatologists. One year later

24. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

25. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases:insights after the first 5 years of the ERN ReCONNET

26. AB1152 COVID-19 mRNA VACCINE BOOSTER IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

27. POS1232 LONG-TERM OUTCOMES OF COVID-19 VACCINATION IN PATIENTS WITH RARE AND COMPLEX CONNECTIVE TISSUE DISEASES: AN AD-INTERIM ANALYSIS OF ERN-ReCONNET VACCINATE STUDY

31. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

34. Undifferentiated connective tissue disease: State of the art on clinical practice guidelines

35. Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines

36. IgG4-related diseases: State of the art on clinical practice guidelines

37. Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9)

39. One year in review 2021: Systemic vasculitis

40. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

41. Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study

44. Antiphospholipid syndrome: State of the art on clinical practice guidelines

45. Systemic sclerosis: State of the art on clinical practice guidelines

46. Relapsing polychondritis: State of the art on clinical practice guidelines

47. Sjögren's syndrome: State of the art on clinical practice guidelines

48. Systemic lupus erythematosus: State of the art on clinical practice guidelines

49. Ehlers-Danlos syndromes: State of the art on clinical practice guidelines

50. One year in review 2020: vasculitis

Catalog

Books, media, physical & digital resources